bioAffinity Technologies ...

NASDAQ: BIAF · Real-Time Price · USD
0.29
0.01 (2.04%)
At close: Jun 09, 2025, 3:59 PM

bioAffinity Revenue Breakdown

Period Ending Dec 31, 2024
Health Care, Patient Service Revenue 516K
Health Care, Patient Service Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Selling, General, and Administrative Revenue 2.45M 2.92M 2.36M 2.47M 2.19M 2.21M 2.02M 1.43M 1.15M 1.43M 596.48K 349.41K 352.52K 289.62K 161.55K 242.62K 186.99K 391.18K
Selling, General, and Administrative Revenue Growth -16.01% +23.50% -4.37% +13.12% -1.26% +9.39% +41.88% +24.27% -19.65% +139.52% +70.71% -0.88% +21.72% +79.28% -33.41% +29.75% -52.20% n/a
Research and Development Revenue 367.39K 518.19K 368.2K 453.89K 442.6K 528.17K 330.38K 370.38K 389.25K 197.25K 380.69K 335.87K 374.52K 370.13K 364.74K 286.95K 304.22K 410.54K
Research and Development Revenue Growth -29.10% +40.73% -18.88% +2.55% -16.20% +59.87% -10.80% -4.85% +97.33% -48.19% +13.34% -10.32% +1.19% +1.48% +27.11% -5.68% -25.90% n/a